Core C - Genomics, Animal Models and Advanced Phenotyping Core
核心 C - 基因组学、动物模型和高级表型分析核心
基本信息
- 批准号:10403631
- 负责人:
- 金额:$ 38.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-05 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelAnimalsBiological AssayBiological ProcessBreedingCardiovascular ModelsCardiovascular systemCellsCenters of Research ExcellenceClinicalCollectionComplementConsultationsCountryCustomData SetDiseaseEnsureEquipmentFacultyFaculty WorkshopFee-for-Service PlansFundingGene ExpressionGenerationsGenesGenetic EngineeringGenomicsGenotypeGoalsGrantHealthHigh PrevalenceHistorically Black Colleges and UniversitiesInbred MouseInbreedingInfrastructureInstitutionInstructionKidneyKidney DiseasesKnockout MiceLettersMaintenanceMeasurementMedical centerMetabolic DiseasesMethodologyMethylationMississippiModelingMolecularMolecular GeneticsMorbidity - disease rateObesityPhasePhenotypePhysiologicalPopulationPreparationProteinsPublicationsRattusResearchResearch PersonnelResearch Project GrantsScientific Advances and AccomplishmentsScientistServicesSmall RNAStudentsSupervisionSystems BiologyTechnical ExpertiseTechniquesTechnologyTrainingTraining and EducationTransgenic MiceTransgenic OrganismsUnited StatesUnited States National Institutes of HealthUniversitiesWorkanimal model developmentbasebioinformatics toolepigenetic regulationepigenomeexome sequencinggenome sequencinggenomic dataimprovedinsightinstrumentationmeetingsmetabolic phenotypemicrobialmortalitymouse modelmultidisciplinarynext generation sequencingnovelservice deliverytraining opportunitytranscriptometranscriptome sequencingundergraduate studentwhole genome
项目摘要
CORE C – GENOMICS, ANIMAL MODELS AND ADVANCED PHENOTYPING
PROJECT SUMMARY/ABSTRACT
The goal of the Cardiorenal and Metabolic Disease Research Center (CMDRC) COBRE is to bring together
a multidisciplinary group of basic, clinical, and population scientists to work synergistically on the theme of
cardiorenal and metabolic diseases. During Phase 1, CMDRC-Core C provided COBRE investigators and
external researchers' access to technical expertise and equipment to perform a wide variety of molecular,
genetic, microarray and gene expression studies that would otherwise not be possible. Core C also provided
investigators at UMMC access to novel transgenic and knockout mouse and rat models of cardiovascular
renal and metabolic disease that are only available at UMMC. In total, CMDRC-Core C completed several
hundred genomic studies as well as generated thousands of animals for detailed phenotyping resulting in
numerous publications and several NIH R01 funded grants. In Phase II, CMDRC-Core C major project, pilot
grants, and external researchers will have access to state-of-the-art genomic technologies through the
Genomics Sub-Core and large collection of animal models (inbred, transgenic, and gene-edited rat and
mouse models) as well as advanced phenotyping methodologies through the Animal Models and Advanced
Phenotyping Sub-Core. Core C has four aims: (1) to provide CMDRC investigators access to technical
expertise and cutting-edge genomic services, including next generation sequencing technologies (RNA
sequencing, 16S microbial sequencing, custom amplicon panels, whole genome sequencing, and exome
sequencing); (2) to provide CMDRC investigators access to large collection of unique animal models of
obesity, cardiorenal and metabolic diseases, along with training in advanced phenotyping techniques; (3) to
provide education and training opportunities for students, trainees, and faculty in genomics technologies and
advanced animal phenotyping; and (4) to provide continuous improvement in existing assays, services, and
enhance technological capabilities through acquisition of new cutting-edge instrumentation that will assist in
sustainability of the Core. Therefore, it is the objective of the CMDRC-Core C to aid investigators in advancing
scientific discovery in obesity, cardiorenal, and metabolic diseases through application of state-of-the-art
genomic technologies, specialized animal models, and advanced physiological measurements to generate
greater insight into these diseases. Aside from CMDRC investigators, continued funding of the COBRE during
Phase II will have a significant impact on providing external researchers (at other Mississippi undergraduate
institutions and Historically Black Colleges and Universities (HBCUs)] access to equipment and expertise that
would otherwise not be available in our region of the country.
核心C - 基因组学,动物模型和先进的表型
项目摘要/摘要
心脏和代谢性疾病研究中心(CMDRC)的目标是将
一个基本,临床和人群科学家组成的多学科小组,以协同为主题
心脏和代谢性疾病。在第1阶段,CMDRC核C提供了毛to研究者和
外部研究人员获得技术专长和设备的访问,以执行各种分子
否则不可能的遗传,微阵列和基因表达研究。核心也提供了
UMMC访问新型转基因和敲除鼠标的研究人员以及心血管的大鼠模型
仅在UMMC上可用的肾脏和代谢疾病。 CMDRC核C总共完成了几个
数百种基因组研究以及生成数千只动物进行详细的表型,导致
许多出版物和几项NIH R01资助的赠款。在第二阶段,CMDRC核C大项目,飞行员
赠款,外部研究人员将可以通过
基因组学亚核和大量动物模型(近交,转基因和基因编辑的大鼠,以及
小鼠模型)以及通过动物模型和先进的高级表型方法
表型子核。 Core C有四个目标:(1)为CMDRC调查人员提供技术访问
专业知识和尖端基因组服务,包括下一代测序技术(RNA
测序,16S微生物测序,自定义扩增子面板,整个基因组测序和外显子组
测序); (2)为CMDRC调查人员提供大量独特动物模型的访问
肥胖,心脏和代谢疾病,以及晚期表型技术的训练; (3)到
为基因组技术的学生,学员和教师提供教育和培训机会,
先进的动物表型; (4)为现有测定,服务和
通过获取新的尖端仪器来增强技术能力,这将有助于
核心的可持续性。因此,CMDRC核C的目的是帮助调查人员前进
肥胖,心脏和代谢性疾病的科学发现通过最先进
基因组技术,专业动物模型和高级物理测量以生成
对这些疾病的洞察力更大。除了CMDRC调查人员,在
第二阶段将对提供外部研究人员产生重大影响(在其他密西西比州本科
机构和历史上的黑人学院和大学(HBCUS)]获得设备和专业知识
否则在我们该国地区将不可用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL R GARRETT其他文献
MICHAEL R GARRETT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL R GARRETT', 18)}}的其他基金
Omics, Bioinformatics and Flow Cytometry Core
组学、生物信息学和流式细胞术核心
- 批准号:
10630580 - 财政年份:2023
- 资助金额:
$ 38.62万 - 项目类别:
Core A- Administration, Education, and Mentoring
核心 A- 管理、教育和指导
- 批准号:
10553865 - 财政年份:2023
- 资助金额:
$ 38.62万 - 项目类别:
Genetic Targets of Hypertension End Organ Damage
高血压终末器官损伤的遗传靶标
- 批准号:
10198017 - 财政年份:2018
- 资助金额:
$ 38.62万 - 项目类别:
Genetic Targets of Hypertension End Organ Damage
高血压终末器官损伤的遗传靶标
- 批准号:
9920359 - 财政年份:2018
- 资助金额:
$ 38.62万 - 项目类别:
Core C - Genomics, Animal Models and Advanced Phenotyping Core
核心 C - 基因组学、动物模型和高级表型分析核心
- 批准号:
10159921 - 财政年份:2013
- 资助金额:
$ 38.62万 - 项目类别:
Genetics of Renal End Organ Damage in Hypertension
高血压肾终末器官损伤的遗传学
- 批准号:
8477235 - 财政年份:2009
- 资助金额:
$ 38.62万 - 项目类别:
Genetics of Renal End Organ Damage in Hypertension
高血压肾终末器官损伤的遗传学
- 批准号:
8289584 - 财政年份:2009
- 资助金额:
$ 38.62万 - 项目类别:
相似国自然基金
基于扁颅蝠类群系统解析哺乳动物脑容量适应性减小的演化机制
- 批准号:32330014
- 批准年份:2023
- 资助金额:215 万元
- 项目类别:重点项目
基于供应链视角的动物源性食品中抗微生物药物耐药性传导机制及监管策略研究
- 批准号:72303209
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于基因组数据自动化分析为后生动物类群大规模开发扩增子捕获探针的实现
- 批准号:32370477
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
大型野生动物对秦岭山地森林林下植物物种组成和多样性的影响及作用机制
- 批准号:32371605
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
闸坝建设对河口大型底栖动物功能与栖息地演变的影响-以粤西鉴江口为例
- 批准号:42306159
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 38.62万 - 项目类别:
The Role of Astrocyte Elevated Gene-1 (AEG-1), A Novel Multifunctional Protein, In Chemotherapy-Induced Peripheral Neuropathy
星形胶质细胞升高基因 1 (AEG-1)(一种新型多功能蛋白)在化疗引起的周围神经病变中的作用
- 批准号:
10679708 - 财政年份:2023
- 资助金额:
$ 38.62万 - 项目类别:
Behavioral and physiological measurements of hearing in mouse models of Alzheimer's Disease
阿尔茨海默病小鼠模型听力的行为和生理测量
- 批准号:
10647340 - 财政年份:2023
- 资助金额:
$ 38.62万 - 项目类别:
Novel first-in-class Therapeutics for Rheumatoid Arthritis
类风湿关节炎的一流新疗法
- 批准号:
10696749 - 财政年份:2023
- 资助金额:
$ 38.62万 - 项目类别:
Achieving Sustained Control of Inflammation to Prevent Post-Traumatic Osteoarthritis (PTOA)
实现炎症的持续控制以预防创伤后骨关节炎 (PTOA)
- 批准号:
10641225 - 财政年份:2023
- 资助金额:
$ 38.62万 - 项目类别: